GUIDED THERAPEUTICS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Guided Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
Guided Therapeutics Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$655K, a 56.5% increase year-over-year.
Guided Therapeutics Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$2.12M, a 53% increase year-over-year.
Guided Therapeutics Inc annual Operating Income (Loss) for 2023 was -$3.46M, a 3.72% decline from 2022.
Guided Therapeutics Inc annual Operating Income (Loss) for 2022 was -$3.33M, a 41.1% decline from 2021.
Guided Therapeutics Inc annual Operating Income (Loss) for 2021 was -$2.36M, a 125% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$2.12M	-$655K	+$850K	+56.5%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	-$2.97M	-$359K	+$484K	+57.4%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	-$3.46M	-$486K	+$463K	+48.8%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-28
Q3 2023	-$3.92M	-$623K	+$601K	+49.1%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	-$4.52M	-$1.51M	-$788K	-110%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-14
Q1 2023	-$3.73M	-$843K	-$400K	-90.3%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-14
Q4 2022	-$3.33M	-$949K	-$458K	-93.3%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-28
Q3 2022	-$2.88M	-$1.22M	-$737K	-151%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	-$2.14M	-$717K	-$156K	-27.8%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	-$1.98M	-$443K	+$380K	+46.2%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	-$2.36M	-$491K	-$203K	-70.5%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-30
Q3 2021	-$2.16M	-$487K	-$334K	-218%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$1.83M	-$561K	-$192K	-52%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-15
Q1 2021	-$1.63M	-$823K	-$581K	-240%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-16
Q4 2020	-$1.05M	-$288K	-$123K	-74.5%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-30
Q3 2020	-$929K	-$153K	+$35K	+18.6%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15
Q2 2020	-$964K	-$369K	-$42K	-12.8%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-18
Q1 2020	-$922K	-$242K	+$15K	+5.84%	Jan 1, 2020	Mar 31, 2020	10-Q/A	2021-08-18
Q4 2019	-$937K	-$165K	+$282K	+63.1%	Oct 1, 2019	Dec 31, 2019	10-K	2021-04-07
Q3 2019	-$1.22M	-$188K	+$46K	+19.7%	Jul 1, 2019	Sep 30, 2019	10-Q/A	2020-11-05
Q2 2019	-$1.27M	-$327K	+$164K	+33.4%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-20
Q1 2019	-$1.43M	-$257K	+$119K	+31.6%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-07-07
Q4 2018	-$1.55M	-$447K	+$288K	+39.2%	Oct 1, 2018	Dec 31, 2018	10-K	2020-04-20
Q3 2018	-$1.84M	-$234K	+$1.11M	+82.5%	Jul 1, 2018	Sep 30, 2018	10-Q	2020-03-09
Q2 2018	-$2.94M	-$491K	+$42K	+7.88%	Apr 1, 2018	Jun 30, 2018	10-Q	2020-02-11
Q1 2018	-$2.98M	-$376K	+$138K	+26.8%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-07-11
Q4 2017	-$3.12M	-$735K	+$378K	+34%	Oct 1, 2017	Dec 31, 2017	10-K	2019-05-08
Q3 2017	-$3.5M	-$1.34M	-$660K	-97.2%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-14
Q2 2017	-$2.84M	-$533K	+$365K	+40.6%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-14
Q1 2017	-$3.2M	-$514K	+$616K	+54.5%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-21
Q4 2016	-$3.82M	-$1.11M	+$187K	+14.4%	Oct 1, 2016	Dec 31, 2016	10-K/A	2018-04-20
Q3 2016	-$4.01M	-$679K	+$1.16M	+63.1%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-20
Q2 2016	-$5.17M	-$898K	+$703K	+43.9%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-18
Q1 2016	-$5.87M	-$1.13M	+$358K	+24.1%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-22
Q4 2015	-$6.23M	-$1.3M	+$848K	+39.5%	Oct 1, 2015	Dec 31, 2015	10-K	2017-03-22
Q3 2015	-$7.08M	-$1.84M	+$577K	+23.9%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-12-05
Q2 2015	-$7.65M	-$1.6M	+$426K	+21%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-17
Q1 2015	-$8.08M	-$1.49M	+$591K	+28.4%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-19
Q4 2014	-$8.67M	-$2.15M	-$798K	-59.1%	Oct 1, 2014	Dec 31, 2014	10-K	2016-03-15
Q3 2014	-$7.87M	-$2.42M	-$775K	-47.3%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-12
Q2 2014	-$7.1M	-$2.03M	-$286K	-16.4%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-13
Q1 2014	-$6.81M	-$2.08M	-$204K	-10.9%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-13
Q4 2013	-$6.61M	-$1.35M	-$183K	-15.7%	Oct 1, 2013	Dec 31, 2013	10-K	2015-03-25
Q3 2013	-$6.42M	-$1.64M	-$670K	-69.1%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-12
Q2 2013	-$5.75M	-$1.74M	-$593K	-51.7%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-13
Q1 2013	-$5.16M	-$1.88M	-$879K	-88.3%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-15
Q4 2012	-$4.28M	-$1.17M	+$1.72M	+59.5%	Oct 1, 2012	Dec 31, 2012	10-K	2014-03-26
Q3 2012	-$6M	-$970K	+$1.68M	+63.4%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-13
Q2 2012	-$7.68M	-$1.15M	-$663K	-137%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-14
Q1 2012	-$7.01M	-$996K	-$256K	-34.6%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-14
Q4 2011	-$6.76M	-$2.88M			Oct 1, 2011	Dec 31, 2011	10-K	2013-03-27
Q3 2011		-$2.65M			Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-13
Q2 2011		-$485K	+$46K	+8.66%	Apr 1, 2011	Jun 30, 2011	10-Q/A	2012-08-24
Q1 2011		-$740K			Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-14
Q2 2010		-$531K			Apr 1, 2010	Jun 30, 2010	10-Q	2011-11-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.